Pfizer’s Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle Grant Type Focus Area Country Application Due Date Transthyretin Cardiac Amyloidosis Fellowship - United StatesRelease Date:Fellowship Rare Disease USA Exploring the Use of Artificial Intelligence (AI) Applications in ALK+ NSCLCRelease Date:Quality Improvement, Research Oncology Italy Sickle Cell Disease (SCD) FellowshipRelease Date:Fellowship Rare Disease USA 2025 Headache Medicine Fellowship - USRelease Date:Fellowship Internal Medicine USA Sickle Cell Disease Visiting Professorship ProgramRelease Date:Education Rare Disease USA Research on Diagnostic and Treatment of Invasive Mold DiseaseRelease Date:Research Hospital China Optimizing Care for Patients with HR+/HER2- or HER2+ (regardless of hormonal status) metastatic Breast Cancer (mBC)Release Date:Education Oncology Spain Addressing Barriers to Cancer Care for AIAN and NHPI IndividualsQuality Improvement Oncology USA Research on Disease Burden of CRE (including non-MBL and MBL-CRE), CR-PA and Stenotrophomonas Maltophilia in ChinaRelease Date:Research Hospital China Educational approaches to address immunization practice gaps and improve adult vaccination coverage in SwitzerlandRelease Date:Education Vaccines Switzerland China Medical Education in Non-small Cell Lung Cancer Diagnosis, Treatment and Long-Term Disease ManagementRelease Date:Education Oncology China Title Grant Type Focus Area Country Application Due Date Hemophilia Research in Africa-Middle East, Asia Pacific, China and Latin AmericaRelease Date:Research Rare Disease All Rheumatic diseases such as SLE, SS, SSc, vasculitis syndromeRelease Date:Education Inflammation & Immunology Japan Optimal treatment and management of Rheumatoid ArthritisRelease Date:Education Inflammation & Immunology Japan Education relating to Etiology, diagnosis, treatment and, management of SpondyloarthritisRelease Date:Education Inflammation & Immunology Japan Inflammation ASPIRE Rheumatology: Europe (except Germany), Israel, Turkey, Russia, Australia, New Zealand, Japan and South KoreaRelease Date:Research Inflammation & Immunology All Inflammation ASPIRE Ulcerative Colitis:Europe (except Germany), Israel, Turkey,Russia,Australia,New Zealand, Japan, South KoreaRelease Date:Research Inflammation & Immunology All Raising Awareness and Promoting Timely Diagnosis of TTR AmyloidosisRelease Date:Quality Improvement Rare Disease All Hemophilia: Improve general knowledge level of gene therapyRelease Date:Education Rare Disease Japan Providing Enhanced Medical Support for Patients with Primary Immunodeficiency (PI) DisordersRelease Date:Education Internal Medicine USA Serotyping of Streptococcus pneumoniaeRelease Date:Education Vaccines Japan Artificial Intelligence/Machine Learning Research in HemophiliaRelease Date:Research Rare Disease USA Education of Healthcare Professionals to Provide Appropriate Medical Care for IBD PatientsRelease Date:Education Inflammation & Immunology Japan